|Mylan N V -- USA Stock|| |
USD 46.64 0.26 0.55%
Dr. Joseph C. Maroon, M.D., is an Independent Director of Mylan Inc., since 2003. Dr. Maroon is currently Professor, Heindl Scholar in Neuroscience and Vice Chairman of the Department of Neurosurgery, University of Pittsburgh Medical Center, and has held other positions at UPMC since 1998. He has also served as the team neurosurgeon for the Pittsburgh Steelers since 1981. From 1995 to 1998, Dr. Maroon was Professor and Chairman of the Department of Surgery at Allegheny General Hospital, and from 1984 to 1999 he was Professor and Chairman of the Department of Neurosurgery at Allegheny General Hospital. Dr. Maroon has earned numerous awards for his contributions to neurosurgery from various national and international neurological societies throughout his career, and patients travel from all over the world to seek his care.
Age: 73 Director Since 2003
44 1707 853000 http://www.mylan.com
Joseph Maroon Latest Insider Activity
The company has Return on Asset of 3.79 %
which means that on every $100 spent on asset it made $3.79 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE)
of 6.92 %
implying that it generated $6.92 on every 100 dollars invested.
The company has 14.72 B in debt with debt to equity (D/E) ratio of 110.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Mylan N V has Current Ratio of 1.43 which is typical for the industry and considered as normal.
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. Mylan N V (MYL) is traded on NASDAQ in USA. It is located in UNITED KINGDOM and employs 35,000 people. Mylan N is listed under Pharmaceutical Products category by Fama And French industry classification.